Souhaitez-vous accéder aux communiqués récents ?

TORONTO, 31 mars 2026 (GLOBE NEWSWIRE) -- Le Conseil canadien sur la reddition de comptes (CCRC), l’organisme de réglementation effectuant l’audit des sociétés ouvertes du Canada, a publié son...

CPAB, Canada’s public company audit regulator, has released its 2025 annual report, Transparency, Technology and Trust in a Changing Landscape.

Agios announces it will pursue U.S. accelerated approval for mitapivat in sickle cell disease

SupplySide Connect New Jersey, April 14-15, returns to bring the top manufacturers and suppliers together to source new ingredients and gain insights

TORONTO, 11 mars 2026 (GLOBE NEWSWIRE) -- Le Conseil canadien sur la reddition de comptes (CCRC) a publié ses premiers rapports d’inspection de chaque cabinet, marquant ainsi une étape importante...

CPAB has published its first individual firm inspection reports, marking a significant milestone in the evolution of CPAB’s public disclosure practices.

PYRUKYND (mitapivat) approved for adults with thalassemia in the United Arab Emirates

RxLogic Affirms Commitment to Compliance and Transparency as PBM Regulatory Expectations Expand

Siren Biotechnology Receives FDA Fast Track Designation for SRN-101 for the Treatment of Recurrent High-Grade Glioma

Agios today announced that the U.S. FDA has approved AQVESME™ (mitapivat), an oral pyruvate kinase (PK) activator, for thalassemia